Cargando…

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia

Hematological malignancies possess a distinctive immunologic microenvironment compared with solid tumors. Here, using an established computational algorithm (CIBERSORT), we systematically analyzed the overall distribution of 22 tumor-infiltrating leukocyte (TIL) populations in more than 2000 bone ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zi-Jun, Gu, Yu, Wang, Cui-Zhu, Jin, Ye, Wen, Xiang-Mei, Ma, Ji-Chun, Tang, Li-Juan, Mao, Zhen-Wei, Qian, Jun, Lin, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959428/ https://www.ncbi.nlm.nih.gov/pubmed/32002295 http://dx.doi.org/10.1080/2162402X.2019.1683347

Ejemplares similares

ALOX5AP is a new prognostic indicator in acute myeloid leukemia
por: Chen, Xin-Yi, et al.
Publicado: (2023)

Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021)

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
por: Wang, Shi-sen, et al.
Publicado: (2021)

TMEM206 is a potential prognostic marker of hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016)

CD206(+)CD68(+) mono-macrophages and serum soluble CD206 level are increased in antineutrophil cytoplasmic antibodies associated glomerulonephritis
por: An, Xiao-Ning, et al.
Publicado: (2022)

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020)

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
por: Ren, Chun-Xia, et al.
Publicado: (2017)

Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
por: Scodeller, Pablo, et al.
Publicado: (2017)

CD206+ M2-Like Macrophages Are Essential for Successful Implantation
por: Ono, Yosuke, et al.
Publicado: (2020)

Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206
por: Feinberg, Hadar, et al.
Publicado: (2021)

Critical role of CD206+ macrophages in organizing anti-tumor immunity
por: Ray, Arja, et al.
Publicado: (2023)

Ciprofloxacin promotes polarization of CD86(+)CD206(−) macrophages to suppress liver cancer
por: Fan, Mengtian, et al.
Publicado: (2020)

Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia
por: Rogers, Sally L, et al.
Publicado: (2010)

CD86(+)/CD206(+) tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
por: Sun, Dalong, et al.
Publicado: (2020)

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis
por: Suzuki, Yuzo, et al.
Publicado: (2018)

Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia
por: Kazuo, Tsuchiya, et al.
Publicado: (2019)

Human CD206(+) macrophages associate with diabetes and adipose tissue lymphoid clusters
por: Muir, Lindsey A., et al.
Publicado: (2022)

Liver fibrosis and CD206(+) macrophage accumulation are suppressed by anti-GM-CSF therapy
por: Tan-Garcia, Alfonso, et al.
Publicado: (2019)

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia
por: Xu, Zi‐jun, et al.
Publicado: (2022)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
por: Liang, Tianqi, et al.
Publicado: (2022)

Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2018)

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
por: Xu, Zi-jun, et al.
Publicado: (2022)

SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2019)

CD86(+)/CD206(+), Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis
por: Dong, Pingping, et al.
Publicado: (2016)

Characteristics and clinical significance of CD163+/CD206+M2 mono-macrophage in the bladder cancer microenvironment
por: KONG, Xiangjie, et al.
Publicado: (2021)

Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206(+) M2-like macrophage polarization
por: Wang, Jie, et al.
Publicado: (2020)

Microglial CD206 Gene Has Potential as a State Marker of Bipolar Disorder
por: Ohgidani, Masahiro, et al.
Publicado: (2017)

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022)

Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis
por: Shen, Ya-Wen, et al.
Publicado: (2020)

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
por: Liu, Yongliang, et al.
Publicado: (2021)

Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia
por: Tsuchiya, Kazuo, et al.
Publicado: (2020)

CD206(+) tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
por: Modak, Madhura, et al.
Publicado: (2022)

The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-Analysis
por: Debacker, Jens M., et al.
Publicado: (2021)

CircRAD18 Accelerates the Progression of Acute Myeloid Leukemia by Modulation of miR-206/PRKACB Axis
por: Wang, Yanyan, et al.
Publicado: (2020)

Overexpression of CD163, CD204 and CD206 on Alveolar Macrophages in the Lungs of Patients with Severe Chronic Obstructive Pulmonary Disease
por: Kaku, Yoichiro, et al.
Publicado: (2014)

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
por: Romão, Ema, et al.
Publicado: (2020)

Recruited CD68(+)CD206(+) macrophages orchestrate graft immune tolerance to prompt xenogeneic-dentin matrix-based tooth root regeneration
por: Li, Hui, et al.
Publicado: (2020)

CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia
por: Yakymiv, Yuliya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tvnaf5ok19rt1gmm1jpjqe7g6v